242 related articles for article (PubMed ID: 27996332)
1. DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
Lee AW; Jordanov E; Boisnard F; Marshall GS
Expert Rev Vaccines; 2017 Feb; 16(2):85-92. PubMed ID: 27996332
[TBL] [Abstract][Full Text] [Related]
2. Integrated Safety Profile of a New Approved, Fully Liquid DTaP5-HB-IPV-Hib Vaccine.
Xu J; Stek JE; Ziani E; Liu GF; Lee AW
Pediatr Infect Dis J; 2019 Apr; 38(4):439-443. PubMed ID: 30882742
[TBL] [Abstract][Full Text] [Related]
3. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Arístegui J; Dal-Ré R; Díez-Delgado J; Marés J; Casanovas JM; García-Corbeira P; De Frutos E; Van Esso D; Verdaguer J; De la Flor J; Moraga F; Boceta R; García-Martínez JA
Vaccine; 2003 Sep; 21(25-26):3593-600. PubMed ID: 12922087
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.
Lalwani SK; Agarkhedkar S; Sundaram B; Mahantashetti NS; Malshe N; Agarkhedkar S; Van Der Meeren O; Mehta S; Karkada N; Han HH; Mesaros N
Hum Vaccin Immunother; 2017 Jan; 13(1):120-127. PubMed ID: 27629913
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
[TBL] [Abstract][Full Text] [Related]
7. Disparate kinetics in immune response of two different
Martinón-Torres F; Salamanca de la Cueva I; Horn M; Westerholt S; Bosis S; Meyer N; Cheuvart B; Virk N; Jakes RW; Duchenne M; Van den Steen P
Hum Vaccin Immunother; 2024 Dec; 20(1):2342630. PubMed ID: 38687024
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants.
Mallet E; Fabre P; Pines E; Salomon H; Staub T; Schödel F; Mendelman P; Hessel L; Chryssomalis G; Vidor E; Hoffenbach A;
Pediatr Infect Dis J; 2000 Dec; 19(12):1119-27. PubMed ID: 11144370
[TBL] [Abstract][Full Text] [Related]
9. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pichichero ME; Blatter MM; Reisinger KS; Harrison CJ; Johnson CE; Steinhoff MC; Senders SD; Rothstein EP; Willems P; Howe BJ
Pediatr Infect Dis J; 2002 Sep; 21(9):854-9. PubMed ID: 12352809
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule.
Avdicová M; Prikazský V; Hudecková H; Schuerman L; Willems P
Eur J Pediatr; 2002 Nov; 161(11):581-7. PubMed ID: 12424582
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial.
Pérez Chacón G; Estcourt MJ; Totterdell J; Marsh JA; Perrett KP; Campbell DE; Wood N; Gold M; Waddington CS; O' Sullivan M; McAlister S; Curtis N; Jones M; McIntyre PB; Holt PG; Richmond PC; Snelling T
PLoS Med; 2024 Jun; 21(6):e1004414. PubMed ID: 38857311
[TBL] [Abstract][Full Text] [Related]
12. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
[TBL] [Abstract][Full Text] [Related]
13. Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
Wijmenga-Monsuur AJ; van Westen E; Knol MJ; Jongerius RM; Zancolli M; Goldblatt D; van Gageldonk PG; Tcherniaeva I; Berbers GA; Rots NY
PLoS One; 2015; 10(12):e0144739. PubMed ID: 26658902
[TBL] [Abstract][Full Text] [Related]
14. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age.
Mills E; Gold R; Thipphawong J; Barreto L; Guasparini R; Meekison W; Cunning L; Russell M; Harrison D; Boyd M; Xie F
Vaccine; 1998 Apr; 16(6):576-85. PubMed ID: 9569468
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
West DJ; Rabalais GP; Watson B; Keyserling HL; Matthews H; Hesley TM
BioDrugs; 2001; 15(6):413-8. PubMed ID: 11520252
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination.
Virta M; Soininen A; Patel DM; Petit C; Tabar C; Lyabis O
Pediatr Infect Dis J; 2021 Jan; 40(1):e28-e30. PubMed ID: 33284254
[TBL] [Abstract][Full Text] [Related]
19. The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine.
Hogg K; Hogg G
Vaccine; 2003 Jun; 21(21-22):2906-10. PubMed ID: 12798634
[TBL] [Abstract][Full Text] [Related]
20. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
Guerra A; Costantino C; Martinon-Torres F; Westerholt S; Lambeth C; Chen Z; Lumley J; Marcek T; Johnson D; Wilck M
Hum Vaccin Immunother; 2024 Dec; 20(1):2310900. PubMed ID: 38327239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
